GlaxoSmithKline, Teva, Takeda Investing in Global Sustainability Performance with the Responsible Health Initiative

February 6, 2019 EcoVadis EN


Three leading health and pharmaceutical companies -- GlaxoSmithKline, Teva, Takeda – and EcoVadis, the leading provider of sustainability risk and performance ratings for global supply chains, today announced the launch of the Responsible Health Initiative. The mission of the new sector initiative is to use collaboration and technology to improve the visibility, efficiency and sustainability impact of the global health supply chain.


About the Author

EcoVadis EN

EcoVadis is a purpose-driven company dedicated to embedding sustainability intelligence into every business decision worldwide. We offer a full range of solutions including IQ-Plus Risk & Compliance Management, EcoVadis Ratings, and Carbon Action Module for Scope 3 Decarbonization. Key features like 360/Live News Monitoring, Academy E-learning and Corrective action plans help companies comply with ESG regulations, reduce GHG emissions, and improve the sustainability performance of their business and value chain across 250 industries in 185 countries.

Follow on Twitter Follow on Linkedin Visit Website More Content by EcoVadis EN
Previous Article
Improving the Lot of the Global Supply-Chain Worker
Improving the Lot of the Global Supply-Chain Worker

EcoVadis is another entity to employ technology to monitor factory conditions. It provides an online platfo...

Next Article
New in Sustainability: Megatrends Driving Opportunity for Change
New in Sustainability: Megatrends Driving Opportunity for Change

The global business community has made solid improvements in sustainability over the past several years – f...